Cargando…
Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome
Autores principales: | Vaisitti, Tiziana, Vitale, Nicoletta, Micillo, Matilde, Brandimarte, Lorenzo, Iannello, Andrea, Papotti, Mauro Giulio, Jaksic, Ozren, Lopez, Gianluca, Di Napoli, Arianna, Cutrin, Juan Carlos, Orlik, Christian, Kulke, Michael, Pahl, Andreas, Deaglio, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523372/ https://www.ncbi.nlm.nih.gov/pubmed/35914223 http://dx.doi.org/10.1182/blood.2022016211 |
Ejemplares similares
-
Novel Approaches for the Treatment of Patients with Richter’s Syndrome
por: Iannello, Andrea, et al.
Publicado: (2022) -
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
por: Arruga, Francesca, et al.
Publicado: (2020) -
Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL
por: Rejeski, Kai, et al.
Publicado: (2022) -
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor
por: Vaisitti, Tiziana, et al.
Publicado: (2017) -
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?
por: Vaisitti, Tiziana, et al.
Publicado: (2018)